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Background: Although the primary patency of femoropopliteal (FP) stenting has been already established, frequency of repeat revascularization 
remains unclear. In this study, we sought to investigate the clinical outcome of stent implantation for FP artery disease and the frequency of repeat 
revascularization for in-stent restenosis after procedure.
Methods: From September 2000 to December 2008, total 256 patients (285 limbs) with FP artery disease who underwent successful stenting 
were enrolled. Seventy-four percent were male, 51% had diabetes, 15% underwent hemodialysis, and 86% were claudicant patients. 86/79/72/48 
limbs were classified in TASCII Category A/B/C/D respectively. Refractory lesion was defined as the lesion needed for 2nd or more revascularization.
Results: Mean follow-up period was 645±678 days. Nitinol stent was used in 190 limbs (67%). All-cause death was occurred in 24 patients, 
major amputation was performed in 6 patients during the follow up. Kaplan-Meier survival curve showed that freedom from 1st, 2nd, 3rd and 4th 
revascularization (defined as target lesion revascularization and surgical revascularization) at 1 year were 81.9%, 98.2%, 100%, and 100%, those at 
2 years were 72.8%, 87.3%, 96.5% and 100%, respectively. Refractory lesion was 1.8% at 1 year, 12.7% at 2 years.
Conclusions: Although first revascularization rate after FP stenting was slightly high, refractory lesion was rare.
